medigraphic.com
SPANISH

Cirugía y Cirujanos

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 2

<< Back Next >>

Cir Cir 2011; 79 (2)

Atypical intermediate-grade mediastinal carcinoid. Case presentation

Carrillo-Muñoz A, Onofre-Borja M, Borrego-Borrego R, Chávez-Mercado L, Navarro-Reynoso FP, Ibarra-Pérez C
Full text How to cite this article

Language: Spanish
References: 14
Page: 191-195
PDF size: 435.33 Kb.


Key words:

Mediastinum, neuroendocrine tumors, atypical intermediate-grade carcinoid, paraneoplastic syndrome, thoracic surgery.

ABSTRACT

Background: Approximately 25% of carcinoid tumors develop in the respiratory system. Neuroendocrine carcinoids represent ~5% of all mediastinal tumors and 1-5% of all intrathoracic neoplasms. They contain numerous neurosecretory granules that synthesize, store and release neurohumoral substances that can induce the carcinoid syndrome.
Clinical case: A 21-year-old male presented with a rapidly progressive paraneoplastic syndrome unleashed by anacute urethritis. Two left mediastinal masses were identified and resected. Postoperative evolution has been uneventful during the first year.
Conclusions: We emphasize the importance of early detection of primary and satellite lesions of these tumors including neurohumoral markers and PET/CT scans as in this case, as well as the participation of a multidisciplinary team.


REFERENCES

  1. Bini A, Brandolini J, Cassanelli N, Davoli F, Dolci G, Sellitri F, et al. Typical and atypical pulmonary carcinoids: our institutional experience. Interact Cardiovasc Thorac Surg 2008;7:415-418.

  2. Gustaffson BI, Kidd M, Chan A, Malfertheiner M, Modlin I. Bronchopulmonary neuroendocrine tumors. Cancer 2008;113:5-21.

  3. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts. Hematol Oncol Clin North Am 2007;21:395-407.

  4. Ibarra C, Kelly J, Fernández M. Guía diagnóstico-terapéutica: tumores y masas del mediastino. Rev Inst Nal Enf Resp Mex 2001;14:172-177.

  5. Kayser K, Kayser C, Rahn W, Bovin NV, Gabius H. Carcinoid tumors of the lung: immuno- and ligand histochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol 1996;63:99- 06.

  6. Hage R, Brutel de la Rivière A, Seldenrijk A, Van den Bosch J. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003;10:697-704.

  7. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-868.

  8. Taupenot L, Harper K. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-1149.

  9. Macchiarini P, Ostertag H. Uncommon primary mediastinal tumours. Lancet Oncol 2000;5:134-136.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Cir. 2011;79